Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis
NCT06723171
·
clinicaltrials.gov ↗
PHASE2
Phase
SUSPENDED
Status
20
Enrollment
INDUSTRY
Sponsor class
Stopped
Sponsor request for study hold
Conditions
Psoriasis
Plaque Type Psorisis
Plaque Psoriasis
Interventions
DRUG:
IRX4204
OTHER:
Placebo
Sponsor
Io Therapeutics